Recent studies have begun to explore the dark genome and reported large structural variants within known AD risk genes CR1 and ABCA7. There are also regions within INPP5D, IQCK and HLA, as well as valid AD candidate genes, which contain dark areas not assayed by genome-wide genotyping or short read sequencing technologies. This evidence concerns the gene CR1 and Alzheimer disease.